WILLFACT

This brand name is authorized in Austria, Estonia, Lithuania, Poland, Spain, UK.

Active ingredients

The drug WILLFACT contains one active pharmaceutical ingredient (API):

1	Von Willebrand factor from human plasma UNII ZE22NE22F1 - VON WILLEBRAND FACTOR HUMAN
	Administration of von Willebrand factor allows correction of the haemostatic abnormalities exhibited by patients who suffer from von Willebrand factor deficiency.
	Read more about Von Willebrand factor

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
WILLFACT Powder and solvent for solution for injection	MPI, EU: SmPC	Medicines & Healthcare Products Regulatory Agency (GB)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD10	Von Willebrand factor	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD10

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1461978, 1632743, 1632956
ES	Centro de información online de medicamentos de la AEMPS	73760
GB	Medicines & Healthcare Products Regulatory Agency	245562
LT	Valstybinė vaistų kontrolės tarnyba	1053690, 1071938, 1071939
PL	Rejestru Produktów Leczniczych	100247921, 100340508, 100340514